South Korea Nucleotide Market Size, Share, and COVID-19 Impact Analysis, By Technology (TaqMan Allelic Discrimination, SNP By Pyrosequencing, Gene Chips & Microarrays, and Others), By Application (Food & Beverage Additives, Pharmaceuticals, Diagnostics Research, Animal Feed Additive, and Others), and South Korea Nucleotide Market Insights, Industry Trend, Forecasts to 2035

South Korea Nucleotide Market Insights Forecasts to 2035

• The South Korea Nucleotide Market Size Was Estimated at USD 23.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.92% from 2025 to 2035
• The South Korea Nucleotide Market Size is Expected to Reach USD 45.0 Million by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Nucleotide Market Size is anticipated to reach USD 45.0 Million by 2035, Growing at a CAGR of 5.92% from 2025 to 2035. The primary factors boosting market expansion include growing knowledge of the critical function nucleotides play in a variety of biological processes and propelling research and development projects across several scientific fields.

Market Overview

South Korea's nucleotide market encompasses the production and application of nucleotides in various sectors, including biotechnology, pharmaceuticals, and diagnostics. The market includes advancements in genetic research, the growing demand for personalized medicine, and the expansion of the biotechnology industry. The country has a highly advanced research and development infrastructure, supported by leading universities and biotech institutions. Moreover, opportunities lie in the development of novel nucleotide-based therapies, the integration of artificial intelligence in drug discovery, and the increasing global demand for biopharmaceuticals. Initiatives such as the establishment of a national bio committee and the creation of a 1 trillion-won fund are designed to foster innovation and investment in the sector. The government's support for startups and the integration of digital technologies into biotechnology is expected to further propel the growth of the nucleotide market in South Korea.

Report Coverage

This research report categorizes the market for South Korea nucleotide market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea nucleotide market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea nucleotide market.

Driving Factors

The South Korea nucleotide market is driven by increasing demand for functional food and dietary supplements, as consumers prioritize health and wellness. The rising use of nucleotides in infant formula, owing to their immune-boosting properties, further supports market growth. Expanding applications in pharmaceuticals and biotechnology, particularly in vaccine development and cell culture media, also contribute significantly. Also, technological advancements and government support for R&D in life sciences enhance production capabilities. Additionally, the growing aging population and increased awareness of personalized nutrition are creating new opportunities, making South Korea a key player in the Asia-Pacific nucleotide market.

Restraining Factors

South Korea's nucleotide market faces restraints such as high R&D costs, regulatory complexities, and limited domestic raw material availability. Intense global competition and dependence on imports for advanced biotechnology tools can hinder market expansion and slow the pace of innovation and commercialization.

Market Segmentation

The South Korea nucleotide market share is classified into technology and application.

• The taqman allelic discrimination segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea nucleotide market is segmented by technology taqman allelic discrimination, SNP by pyrosequencing, gene chips & microarrays, and others. Among these, the taqman allelic discrimination segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This technology is essential in several domains, including genetic research, pharmacogenomics, and medical diagnostics, since it enables the unmatched precision of single nucleotide polymorphism (SNP) detection and classification.

• The pharmaceuticals segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea nucleotide market is segmented by application into food & beverage additives, pharmaceuticals, diagnostics research, animal feed additives, and others. Among these, the pharmaceuticals segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is due to its essential role in drug development and manufacturing.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea nucleotide market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Korea Gas Corporation
• Lotte Chemical
• Kumho P and B Chemicals
• Daelim Industrial
• Krakatau Posco
• Mitsui and Co.
• Hanjin Energy
• SK Global Chemical
• LG Chem
• Korea Petrochemical Ind
• Hyundai Chemical
• Lotte Advanced Materials
• Others

Recent Development:

• In March 2024, The Korean Nucleotide Archive (KoNA), was a repository of nucleotide sequence data. The Korean Read Archive in KoNA has collected over 477 TB of raw next-generation sequencing data from national genome projects. To ensure data quality and prepare for international alignment, a standard operating procedure was adopted, which is similar to that of the International Nucleotide Sequence Database Collaboration. The standard operating procedure includes quality control processes for submitted data and metadata using an automated pipeline, followed by manual examination.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea nucleotide market based on the below-mentioned segments:

South Korea Nucleotide Market, By Technology

• TaqMan Allelic Discrimination
• SNP by Pyrosequencing
• Gene Chips & Microarrays
• Others

South Korea Nucleotide Market, By Applications

• Food & Beverage Additives
• Pharmaceuticals
• Diagnostics Research
• Animal Feed Additive
• Others